ArticleJournal for immunotherapy of cancer2016

Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial.

Jason J Luke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.